{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:29:45Z","timestamp":1761182985151,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jiac.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T23:36:55Z","timestamp":1549064215000},"page":"337-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study"],"prefix":"10.1016","volume":"25","author":[{"given":"Ryunosuke","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2118-9135","authenticated-orcid":false,"given":"Kazuyoshi","family":"Shigehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Urata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Ofude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.01.004_bib1","first-page":"449","article-title":"Prevention of urinary tract infection and sepsis following transrectal prostate biopsy","volume":"127","author":"Crawford","year":"1982","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1442-2042.2008.02048.x","article-title":"Complication rates of ultrasound-guided prostate biopsy: a nation-wide survey in Japan","volume":"15","author":"Kakehi","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/iju.12207","article-title":"Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study","volume":"21","author":"Campeggi","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1442-2042.2007.01975.x","article-title":"Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy","volume":"15","author":"Miura","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/iju.13511","article-title":"Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: a prospective multicenter study","volume":"25","author":"Chung","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s11255-012-0145-9","article-title":"Bacterial sepsis following prostatic biopsy","volume":"44","author":"Carmignani","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jiac.2019.01.004_bib7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000329520","article-title":"Population pharmacokinetics and penetration into prostatic, seminal, and vaginal fluid for ciprofloxacin, levofloxacin, and their combination","volume":"57","author":"Bulitta","year":"2011","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2019.01.004_bib8","first-page":"20","article-title":"The pharmacokinetics and tissue penetration of the fluoroquinolones","volume":"12","author":"Bergeron","year":"1989","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.jiac.2019.01.004_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1442-2042.2009.02360.x","article-title":"Detection of drug-resistant Escherichia coli in patients with complicated cystitis: analysis of risk factors","volume":"16","author":"Shigehara","year":"2009","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10156-007-0570-3","article-title":"Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis","volume":"14","author":"Shigehara","year":"2008","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.01.004_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/iju.13369","article-title":"Prevention of infectious complications after prostate biopsy procedure","volume":"24","author":"Togo","year":"2017","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jiac.2013.10.003","article-title":"Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study","volume":"20","author":"Togo","year":"2014","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.01.004_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","article-title":"Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies. Time to reassessant microbial prophylaxis?","volume":"62","author":"Carignan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/iju.13308","article-title":"Prevalence and characteristics of fecal antimicrobial-resistant E.coli in a cohort of Japanese men undergoing prostate biopsy","volume":"24","author":"Kamei","year":"2017","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib15","first-page":"50","article-title":"Guidelines on urological infections","author":"Grabe","year":"2015","journal-title":"Eur Assoc Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib16","first-page":"1","article-title":"Best practice policy statement on urologic surgery antimicrobial prophylaxis","volume":"179","author":"Wolf","year":"2014","journal-title":"Am Urol Assoc"},{"key":"10.1016\/j.jiac.2019.01.004_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1442-2042.2007.01869.x","article-title":"Japanese guidelines for prevention of perioperative infections in urological field","volume":"14","author":"Matsumoto","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib18","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1464-410X.2010.09715.x","article-title":"Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates","volume":"107","author":"Batura","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jiac.2019.01.004_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1442-2042.2009.02348.x","article-title":"Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy","volume":"16","author":"Shigemura","year":"2009","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4111\/kju.2011.52.4.289","article-title":"Efficacy of combination use of Beta-lactamase inhibitor with penicillin and fluoroquinolones for antibiotic prophylaxis in transrectal prostate biopsy","volume":"52","author":"Shigemura","year":"2011","journal-title":"Korean J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.urology.2014.10.047","article-title":"Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies","volume":"85","author":"Luong","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.jiac.2019.01.004_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000074526","article-title":"Penetration of antimicrobial agents into the prostate","volume":"49","author":"Charalabopoulos","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2019.01.004_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1442-2042.1998.tb00597.x","article-title":"Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate","volume":"5","author":"Goto","year":"1998","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib24","first-page":"87","article-title":"An overview of the safety of isepamicin in adults","volume":"7","author":"Blum","year":"1995","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jiac.2019.01.004_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jiac.2014.06.011","article-title":"Clinical effectiveness and safety of tazobactam\/piperacillin 4.5 g for the prevention of febrile infectious complication after prostate biopsy","volume":"20","author":"Yasuda","year":"2014","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.01.004_bib26","first-page":"513","article-title":"Prophylactic efficacy of cephamycin plus fluoroquinolones in high risk patients on inhibiting infectious complications after transrectal prostate biopsy","volume":"28","author":"Shigemura","year":"2016","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jiac.2019.01.004_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00345-018-2217-7","article-title":"The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis","volume":"36","author":"Scott","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.jiac.2019.01.004_bib28","first-page":"1275","article-title":"Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care","volume":"187","author":"Taylor","year":"2012","journal-title":"J\u00a0Urol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19300182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19300182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:58:56Z","timestamp":1761159536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19300182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1341321X19300182"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.01.004","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}